Quick Links

Contact Us

Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk.

Authors: Ajay Nehra|||Graham Jackson|||Martin Miner|||Kevin L Billups|||Arthur L Burnett|||Jacques Buvat|||Culley C Carson|||Glenn R Cunningham|||Irwin Goldstein|||Andre T Guay|||Geoff Hackett|||Robert A Kloner|||John Kostis|||Piero Montorsi|||Melinda Ramsey|||Raymond C Rosen|||Richard Sadovsky|||Allen D Seftel|||Charalambos Vlachopoulos|||Frederick C W Wu

Journal: The Journal of urology

Publication Type: Journal Article

Date: 2013

DOI: 10.1016/j.juro.2012.12.107

ID: 23313195

Affiliations:

Affiliations

    Department of Urology, Rush University Medical Center, Chicago, Illinois 60612, USA. Ajay_Nehra@rush.edu|||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Abstract

We established erectile dysfunction as an often neglected but valuable marker of cardiovascular risk, particularly in younger men and men with diabetes. We also reviewed evidence that lifestyle change, combined with informed prescribing of pharmacotherapies used to mitigate cardiovascular risk, can improve overall vascular health and sexual functioning in men with erectile dysfunction.

Chemical List

    Phosphodiesterase 5 Inhibitors